Wrapping Up SABCS 2023
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful discussions, and plenty of networking.
Progress Against Cancer
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful discussions, and plenty of networking.
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
Study supports the use of immune checkpoint inhibitors in an understudied population.
An implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
Some women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
Surgical oncologist Samilia Obeng-Gyasi describes research that shows chronic stress is associated with higher mortality in cancer.
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now